The Journal of Organic Chemistry
Article
2
mmol), GaCl3 (105 mg, 0.6 mmol) and methyl diazoacetate 4a (109
mg, 1.08 mmol). After column chromatography on SiO2 cyclo-
propanes 5d as a mixture of cis- and trans-isomers in ratio 1:1.4 and
alkene 6d were isolated in yields 137.3 mg (75%) and 35.0 mg (19%),
115.5 (d, o-Ar, JCF = 21.4 Hz), 52.5, 52.3 and 52.1 (3 OMe), 40.6
(CH2), 37.1 (CH2Ph). 19F NMR (282.4 MHz, CDCl3): δ −115.5
ppm.
Trimethyl 3-(4-methylbenzyl)cyclopropane-1,1,2-tricarbox-
ylate (5f) and trimethyl 2-(4-methylbenzyl)prop-1-ene-1,1,3-
tricarboxylate (6f). The title compounds were prepared according
to the general procedure from ACDC 1d (136 mg, 0.55 mmol),
GaCl3 (109 mg, 0.62 mmol) and methyl diazoacetate 4a (113 mg, 1.1
mmol). After column chromatography on SiO2 cyclopropanes 5f as a
mixture of cis- and trans-isomers in ratio 1:1.5 and alkene 6f were
isolated in yields 121 mg (69%) and 37.3 mg (21%), respectively.
respectively. Compound 5d: light yellow oil. IR (KBr): υ 3052, 1737
̅
and 1729 br (CO), 1493, 1437, 1275, 1237, 1171, 1123 cm−1.
HRMS (ESI-TOF) m/z: calcd for [M + H]+ C16H17O6ClH (for 35Cl)
1
341.0786; found, 341.0779. Isomer cis-5d: H NMR (300.1 MHz,
CDCl3): δ 7.20−7.15 and 7.31−7.26 (both d, 2 × 2H, C6H4), 3.82,
3.78 and 3.71 (all s, 3 × 3H, 3 OMe), 3.29 (dd, 1H, CHbPh, 2J = 15.5
3
2
3
Hz, J = 5.7 Hz), 3.11 (dd, 1H, CHaPh, J = 15.5 Hz, J = 9.4 Hz),
2.69 (d, 1H, H(2), 3J = 9.4 Hz), 2.18 (ddd, 1H, H(3), 3J = 9.4 Hz, 3Jcis
Compound 5f: colorless oil. IR (KBr): υ 3052, 1741 and 1724 br
̅
(CO), 1516, 1438, 1266, 1171, 1120 cm−1. HRMS (ESI-TOF) m/
z: calcd for [M + H]+ C17H20O6H 321.1324; found, 321.1333. Isomer
cis-5f: 1H NMR (300.1 MHz, CDCl3): δ 7.12 (br. s, 4H, C6H4), 3.83,
3.76 and 3.72 (all s, 3 × 3H, 3 OMe), 3.29 (dd, 1H, CHbPh, 2J = 15.3
= 9.4 Hz, J = 5.7 Hz) ppm. 13C{1H} NMR (75.5 MHz, CDCl3): δ
3
170.5, 169.3 and 165.4 (3 COO), 138.4 (i-Ar), 128.9 and 129.8 (o-
and m-Ar), 128.7 (p-Ar), 53.4, 52.7 and 52.2 (3 OMe), 39.5 (C(1)),
1
33.3 (CH2), 30.1 and 28.6 (C(3) and C(2)). Isomer trans-5d: H
3
2
3
Hz, J = 5.4 Hz), 3.10 (dd, 1H, CHaPh, J = 15.3 Hz, J = 9.4 Hz),
NMR (300.1 MHz, CDCl3): δ 7.31−7.26 and 7.20−7.15 (both m, 2
3
2.68 (d, 1H, H(2), J = 9.5 Hz), 2.34 (s, 3H, Me), 2.21 (ddd, 1H,
× 2H, C6H4), 3.76, 3.71 and 3.70 (all s, 3 × 3H, 3 OMe), 2.92 (dd,
H(3), J = 9.5 Hz, Jcis = 9.5 Hz, J = 5.4 Hz) ppm. 13C{1H} NMR
(75.5 MHz, CDCl3): δ 169.4, 168.8 and 165.5 (3 COO), 136.9 and
135.8 (i- and p-Ar), 129.2 and 128.3 (o- and m-Ar), 53.0, 52.4 and
52.1 (3 OMe), 39.4 (C(1)), 32.7 (CH2), 31.4 and 28.8 (C(3) and
C(2)), 21.0 (Me). Isomer trans-5f: 1H NMR (300.1 MHz, CDCl3): δ
7.13 (br. s, 4H, C6H4), 3.77, 3.73 and 3.70 (all s, 3 × 3H, 3 OMe),
3
3
3
2
3
2
1H, CHbPh, J = 15.4 Hz, J = 6.7 Hz), 2.81 (dd, 1H, CHaPh, J =
3
15.4 Hz, J = 7.2 Hz), 2.78−2.60 (m, 2H, H(2) and H(3)) ppm.
13C{1H} NMR (75.5 MHz, CDCl3): δ 169.5, 168.7 and 166.9 (3
COO), 137.2 (i-Ar), 132.9 (p-Ar), 129.4 and 128.6 (o- and m-Ar),
53.0, 52.9 and 52.6 (3 OMe), 42.0 (C(1)), 32.7 and 32.4 (C(2) and
C(3)), 31.0 (CH2). Compound 6d: light yellow oil. IR (KBr): υ 3048,
̅
2
3
1733 br (CO), 1493, 1436, 1277, 1185, 1094 cm−1. HRMS (ESI-
2.89 (dd, 1H, CHbPh, J = 15.5 Hz, J = 6.9 Hz), 2.81 (dd, 1H,
2
3
TOF) m/z: calcd for [M + H]+ C16H17O6ClH (for 35Cl) 341.0786;
CHaPh, J = 15.5 Hz, J = 7.2 Hz), 2.80−2.65 (m, 2H, H(2) and
H(3) ppm. 13C{1H} NMR (75.5 MHz, CDCl3): δ 169.7, 167.0 and
166.6 (3 COO), 136.0 and 135.6 (i- and p-Ar), 129.3 and 128.0 (o-
and m-Ar), 53.3, 53.0 and 52.6 (3 OMe), 42.1 (C(1)), 33.8 (CH2),
31.4 and 30.2 (C(3) and C(2)), 21.0 (Me). Compound 6f: colorless
1
found, 341.0786. H NMR (300.1 MHz, CDCl3): δ 7.32−7.16 (m,
4H, C6H4), 3.71 (s, 2H, CH2), 3.86, 3.80 and 3.66 (all s, 3 × 3H, 3
OMe), 3.42 (s, 2H, CH2Ph) ppm. 13C{1H} NMR (75.5 MHz,
CDCl3): δ 169.6, 166.2 and 164.5 (3 COO), 150.6 (C(2)), 134.8 (i-
Ar), 130.4 (p-Ar), 130.8 and 128.8 (o- and m-Ar), 128.5 (C(1)), 52.5,
52.3 and 52.1 (3 OMe), 40.7 (CH2), 37.2 (CH2Ph).
oil. IR (KBr): υ 3046, 2401, 1737 and 1728 br (CO), 1436, 1299,
̅
1281, 1169, 1119 cm−1. HRMS (ESI-TOF) m/z: [M + H]+ calcd for
C17H20O6H 321.1333; found, 321.1327. 1H NMR (300.1 MHz,
CDCl3): δ 7.11−7.06 (m, 4H, C6H4), 3.84, 3.77 and 3.64 (all s, 3 ×
3H, 3 OMe), 3.42 (s, 2H, CH2Ph), 2.31 (s, 3H, Me) ppm. 13C{1H}
NMR (75.5 MHz, CDCl3): δ 169.7, 166.4 and 164.5 (3 COO), 151.4
(C(2)), 143.0 (i-Ar), 129.3 and 129.4 (o- and m-Ar), 129.0 (C(1)),
52.5, 52.3 and 52.1 (3 OMe), 41.2 (CH2), 37.1 (CH2Ph), 21.0 (Me).
1,1-Dimethyl 2-neopentyl 3-(4-methylbenzyl)-
cyclopropane-1,1,2-tricarboxylate (5g) and 1,1-dimethyl 3-
neopentyl 2-(4-methylbenzyl)prop-1−ene-1,1,3-tricarboxy-
late (6g). The title compounds were prepared according to the
general procedure from ACDC 1d (188.8 mg, 0.76 mmol), GaCl3
(140.6 mg, 0.79 mmol) and neopenthyl diazoacetate (237.6 mg, 1.52
mmol). After column chromatography on SiO2 compounds 5g (cis/
trans ∼ 1:1.2) and 6g were isolated in yields 177.4 mg (62%) and 54.4
mg (19%), respectively. Compound 5g: colorless oil. HRMS (ESI-
TOF) m/z: calcd for [M + H]+ C21H28O6H 377.1959; found,
377.1960. Isomer cis-5g: 1H NMR (300.1 MHz, CDCl3): δ 7.17−7.07
(m, 4H, Ar), 3.74 (s, 2H, OCH2), 3.77 and 3.73 (both s, 2 × 3H, 2
Trimethyl 3-(4-fluorobenzyl)cyclopropane-1,1,2-tricarboxy-
late (5e) and trimethyl 2-(4-fluorobenzyl)prop-1−ene-1,1,3-
tricarboxylate (6e). The title compounds were prepared according
to the general procedure from ACDC 1c (176 mg, 0.7 mmol), GaCl3
(132 mg, 0.75 mmol) and methyl diazoacetate 4a (141 mg, 1.4
mmol). After column chromatography on SiO2 cyclopropanes 5e as a
mixture of cis- and trans-isomers in ratio 1:1.4 and alkene 6e were
isolated in yields 109.2 mg (48%) and 20.5 mg (9%), respectively.
Compound 5e: light yellow oil. IR (KBr): υ 3051, 1739 and 1729 br
̅
(CO), 1511, 1438, 1270, 1172, 1123 cm−1. HRMS (ESI-TOF) m/
z: calcd for [M + H]+ C16H17O6FH 325.1082; found, 325.1083.
1
Isomer cis-5e: H NMR (300.1 MHz, CDCl3): δ 7.22−7.16 (m, 2H,
m-Ar), 7.02−6.95 (m, 2H, o-Ar), 3.81, 3.77 and 3.71 (all s, 3 × 3H, 3
2
3
OMe), 3.29 (dd, 1H, CHbPh, J = 15.4 Hz, J = 5.9 Hz), 3.11 (dd,
2
3
1H, CHaPh, J = 15.4 Hz, J = 9.1 Hz), 2.68 (d, 2H, H(2)), 2.18
(ddd, 1H, H(3), 3J = 9.3 Hz, 3Jcis = 9.3 Hz, 3J = 5.9 Hz) ppm. 13C{1H}
NMR (75.5 MHz, CDCl3): δ 169.3, 168.7 and 165.4 (3 COO), 161.5
1
4
(d, p-Ar, JCF = 233 Hz), 135.6 (d, i-Ar, JCF = 2.2 Hz), 129.8 (d, m-
Ar, 3JCF = 6.2 Hz), 115.2 (d, o-Ar, 2JCF = 21.6 Hz), 53.3, 52.6 and 52.2
(3 OMe), 39.4 (C(1)), 32.7 (CH2), 30.1 and 28.4 (C(3) and C(2)).
3
2
OMe), 3.30 (dd, 1H, CHbPh, J = 15.3 Hz, J = 5.2 Hz), 3.12 (dd,
1H, CHaPh, 3J = 15.3 Hz, 3J = 9.6 Hz), 2.74 (d, 1H, H(2), 3Jcis = 9.6
3
3
19F NMR (282.4 MHz, CDCl3): δ −116.9 ppm. Isomer trans-5e: H
1
Hz), 2.33 (s, 3H, Me), 2.22 (ddd, 1H, H(3), J = 9.6 Hz, Jcis = 9.6
Hz, 3J = 5.2 Hz), 0.94 (s, 9H, t-Bu) ppm. 13C{1H} NMR (75.5 MHz,
CDCl3): δ 169.4, 167.2 and 165.5 (3 COO), 135.7 (i-Ph), 128.9 (p-
Ph), 128.2 and 127.9 (o- and m-Ph), 74.5 (OCH2), 53.0 and 52.6 (2
OMe), 39.3 (C(1)), 34.0 (C(3)), 31.2(C), 30.5 (C(2)), 28.8 (CH2),
26.3 (t-Bu), 21.0 (Me). Isomer trans-5g: 1H NMR (300.1 MHz,
CDCl3): δ 7.17−7.07 (m, 4H, Ar), 3.76 (s, 2H, OCH2), 3.81 and 3.75
(both s, 2 × 3H, 2 OMe), 2.94−2.82 (m, 2H, CH2Ph), 2.82−2.66 (m,
2H, H(2) and H(3)), 2.33 (s, 3H, Me), 0.95 (s, 9H, t-Bu) ppm.
13C{1H} NMR (75.5 MHz, CDCl3): δ 169.6, 168.5 and 166.6 (3
COO), 136.9 (i-Ph), 129.2 and 129.1 (o- and m-Ph), 129.0 (p-Ph),
74.6 (OCH2), 53.3 and 52.9 (2 OMe), 41.9 (C(1)), 32.9 (C(3)),
31.4 (C(2)), 31.3(C), 31.2 (CH2), 26.4 (t-Bu), 20.9 (Me).
Compound 6g: Colorless oil. HRMS (ESI-TOF) m/z: calcd for [M
+ H]+ C21H28O6H 377.1959; found, 377.1951. 1H NMR (300.1 MHz,
CDCl3): δ 7.17−7.08 (m, 4H, Ar), 3.85 (s, 2H, CH2), 3.77 and 3.75
(both s, 2 × 3H, 2 OMe), 3.47 (s, 2H, CH2), 2.32 (s, 3H, Me), 0.92
(s, 9H, t-Bu). 13C{1H} NMR (75.5 MHz, CDCl3): δ 169.2, 166.5 and
NMR (300.1 MHz, CDCl3): δ 7.22−7.16 (m, 2H, m-Ar), 7.02−6.95
(m, 2H, o-Ar), 3.76, 3.70 and 3.69 (all s, 3 × 3H, 3 OMe), 2.65−2.75
(m, 2H, H(2) and H(3)), 2.88 (dd, 1H, CHbPh, 2J = 15.3 Hz, 3J = 6.8
Hz), 2.76 (dd, 1H, CHaPh, 2J = 15.3 Hz, 3J = 7.2 Hz) ppm. 13C{1H}
NMR (75.5 MHz, CDCl3): δ 169.5, 166.9 and 165.5 (3 COO), 161.4
1
4
(d, p-Ar, JCF = 233 Hz), 134.4 (d, i-Ar, JCF = 2.1 Hz), 129.7 (d, m-
Ar, 3JCF = 6.2 Hz), 115.3 (d, o-Ar, 2JCF = 21.6 Hz), 53.1, 52.7 and 52.4
(3 OMe), 42.0 (C(1)), 33.6 (CH2), 32.7 and 30.9 (C(3) and C(2)).
19F NMR (282.4 MHz, CDCl3): δ −116.7 ppm. Compound 6e: light
yellow oil. IR (KBr): υ 3017, 2401, 1738 and 1728 br (CO), 1510,
̅
1436, 1263, 1172 cm−1. HRMS (ESI-TOF) m/z: calcd for [M + H]+
C16H17O6FH 325.1085; found, 325.1082. 1H NMR (300.1 MHz,
CDCl3): δ 7.29−7.19 (m, 2H, m-Ar), 7.05−6.96 (m, 2H, o-Ar), 3.70
(s, 2H, CH2), 3.86, 3.80 and 3.66 (all s, 3 × 3H, 3 OMe), 3.43 (s, 2H,
CH2Ph) ppm. 13C{1H} NMR (75.5 MHz, CDCl3): δ 166.9 (2 COO),
1
166.3 (COO), 162.4 (d, p-Ar, JCF = 235 Hz), 151.0 (C(2)), 131.7
(d, i-Ar, 4JCF = 2.2 Hz), 131.1 (d, m-Ar, 3JCF = 6.1 Hz), 127.9 (C(1)),
4575
J. Org. Chem. 2021, 86, 4567−4579